--- title: "生物素成分市場展望 2026-2036：根據 FMI 報告，全球市場預計到 2036 年將達到 106.1 億美元，年複合增長率為 10.90%" type: "News" locale: "zh-HK" url: "https://longbridge.com/zh-HK/news/279546640.md" description: "全球生物素成分市場預計將從 2025 年的 34 億美元增長到 2036 年的 106.1 億美元，年均增長率為 10.90%。這一增長受到製藥、補充劑和美容產品需求上升的推動，受健康趨勢的影響。固體生物素預計將主導市場，而製藥部門將佔據最大份額。亞太地區，特別是中國和印度，正成為一個高增長區域。主要參與者包括 DSM、Lonza 和 BASF，專注於高純度配方和合規性" datetime: "2026-03-18T06:56:08.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/279546640.md) - [en](https://longbridge.com/en/news/279546640.md) - [zh-HK](https://longbridge.com/zh-HK/news/279546640.md) --- # 生物素成分市場展望 2026-2036：根據 FMI 報告，全球市場預計到 2036 年將達到 106.1 億美元，年複合增長率為 10.90% _**Global biotin ingredients market grows with rising demand from pharmaceuticals, supplements, and beauty products, driven by wellness trends and advanced formulations**_ **NEWARK, DE / ACCESS Newswire / March 18, 2026 /** According to analysis by **Future Market Insights (FMI)**, the global **biotin ingredients market** is entering a phase of accelerated expansion as demand converges across nutraceutical, pharmaceutical, and beauty-from-within product segments. Rising consumer awareness around hair, skin, and nail health, combined with increasing pharmaceutical applications, is reshaping procurement and formulation strategies across industries. The market was valued at USD 3.40 billion in 2025 and is projected to reach **USD 3.77 billion in 2026**. Over the forecast period, demand is expected to grow at a robust **CAGR of 10.90%,** ultimately reaching **USD 10.61 billion by 2036**. This strong growth trajectory reflects a structural shift toward preventive healthcare and functional nutrition. Rather than serving as a niche vitamin ingredient, biotin is increasingly being positioned as a core functional component across supplements, cosmetics, fortified foods, and pharmaceutical formulations. **Get Access of Report Sample:** https://www.futuremarketinsights.com/reports/sample/rep-gb-25713 **Biotin Ingredients Market Snapshot** - Market Value (2025): USD 3.40 Billion - Forecast Value (2036): USD 10.61 Billion - Forecast CAGR (2026-2036): 10.90% - Leading Type: Solid Biotin (71.3%) - Top Application Segment: Pharmaceutical (34.0%) - Leading Distribution Channel: Direct Sales (46.5%) - Fastest Growing Market: China **Beauty-from-Within Trends Driving Ingredient Demand** A primary force driving the biotin ingredients market is the rapid rise of beauty-from-within trends, where consumers increasingly rely on ingestible supplements for visible improvements in hair, skin, and nail health. Manufacturers are responding by developing high-dose, bioavailable formulations that deliver measurable outcomes. At the same time, pharmaceutical demand remains strong due to biotin's established role in treating biotinidase deficiency and metabolic disorders. FMI analysts note that this dual demand-clinical and cosmetic-is elevating biotin from a commodity vitamin to a high-value functional ingredient. **Supply Chain Concentration and Quality Specifications Shape Procurement** Procurement strategies are increasingly influenced by supply chain concentration and stringent quality requirements. A significant portion of global biotin production is concentrated among fermentation-based manufacturers in China, creating sourcing risks for pharmaceutical-grade material. Key procurement challenges include: - Ensuring pharmacopoeia-grade purity and regulatory compliance - Managing price volatility linked to fermentation feedstock costs - Mitigating single-source supply risks As a result, pharmaceutical and cosmetic manufacturers are increasingly adopting dual-sourcing strategies and long-term supplier agreements to ensure consistency and security. **Solid Biotin Leads Product Segment** By type, solid biotin is projected to dominate the market with a 71.3% share in 2026. Its leadership is driven by operational advantages such as: - Superior stability during storage and processing - Ease of handling in tableting and capsule filling - Precise dosing capabilities for pharmaceutical and nutraceutical applications These benefits make solid biotin the preferred format across large-scale manufacturing environments. **Pharmaceutical Segment Drives Application Demand** The pharmaceutical segment is expected to hold the largest share, accounting for 34.0% of total demand in 2026. This dominance is supported by: - Established therapeutic use in biotin deficiency treatment - Growing off-label use in high-dose wellness formulations - Increasing demand for clinically validated ingredients Pharmaceutical-grade biotin continues to command premium pricing due to strict quality specifications and regulatory requirements. **Direct Sales Channel Dominates Distribution** By distribution channel, direct sales are projected to account for 46.5% of the market in 2026. This reflects the B2B nature of the industry, where manufacturers procure ingredients directly from API suppliers under long-term quality agreements. Meanwhile, online channels are emerging as the fastest-growing segment, enabling smaller supplement brands to source ingredients more efficiently and bypass traditional intermediaries. **Asia-Pacific Emerges as a High-Growth Region** Regionally, the biotin ingredients market is witnessing strong growth across Asia-Pacific, driven by expanding manufacturing capacity and rising consumer demand for wellness products. **Biotin Ingredients Market Growth by Country (2026-2036)** - China: 14.7% - India: 13.6% - Germany: 12.5% - France: 11.4% - United Kingdom: 10.4% - United States: 9.3% - Brazil: 8.2% China leads global growth, supported by large-scale fermentation production and increasing domestic consumption. India follows closely, driven by rising awareness of nutritional supplements and expanding middle-class demand. **Innovation in Bioavailability and Formulation Unlocking Opportunities** Technological advancements are enhancing the performance and application scope of biotin ingredients. Manufacturers are investing in advanced encapsulation techniques and delivery systems to improve bioavailability and stability. At the same time, integration into functional foods and beverages is opening new revenue streams, with applications expanding into protein drinks, cereals, and fortified snacks. These innovations are positioning biotin as a versatile ingredient across multiple end-use industries. **Key Players in the Biotin Ingredients Market** Leading companies operating in the global market include: - DSM - Lonza - BASF - Merck - Evonik - Archer Daniels Midland (ADM) - Cargill - Ingredion - Glanbia Nutritionals - Kerry Group - Brenntag - IMCD - Prinova Group - Balchem - Associated British Foods (ABF) These players are focusing on high-purity formulations, regulatory compliance, and global supply chain capabilities to strengthen their competitive positioning. **Market Outlook: Biotin Becomes Core to Wellness Formulations** The long-term outlook for the biotin ingredients market remains highly positive as demand for preventive healthcare, functional nutrition, and beauty supplements continues to rise. With increasing integration across pharmaceuticals, nutraceuticals, cosmetics, and functional foods, biotin is transitioning from a supplementary ingredient to a foundational component in modern wellness product development. As innovation in formulation, sourcing strategies, and delivery mechanisms accelerates, the market is set for sustained high-growth through 2036-cementing biotin's role as a key driver in next-generation health and beauty solutions. **For an in-depth analysis of evolving formulation trends and to access the complete strategic outlook for the Biotin Ingredients Market through 2036, Full Report Request -** https://www.futuremarketinsights.com/reports/biotin-ingredients-market **Related Reports:** Biotin Supplement Market: https://www.futuremarketinsights.com/reports/biotin-supplements-market Biotin Gummies Market: https://www.futuremarketinsights.com/reports/biotin-gummies-market Milk Ingredients Market: https://www.futuremarketinsights.com/reports/milk-ingredients-market Malt Ingredients Market: https://www.futuremarketinsights.com/reports/malt-ingredients-market Bean Ingredients Market: https://www.futuremarketinsights.com/reports/bean-ingredients-market **About Future Market Insights (FMI)** Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. Headquartered in Delaware, USA, with a global delivery center in India and offices in the UK and UAE, FMI delivers actionable insights to businesses across industries including automotive, technology, consumer products, manufacturing, energy, and chemicals. An ESOMAR-certified research organization, FMI provides custom and syndicated market reports and consulting services, supporting both Fortune 1,000 companies and SMEs. Its team of 300+ experienced analysts ensures credible, data-driven insights to help clients navigate global markets and identify growth opportunities. **For Press & Corporate Inquiries** Rahul Singh AVP - Marketing and Growth Strategy Future Market Insights, Inc. +91 8600020075 For Sales - sales@futuremarketinsights.com For Media - Rahul.singh@futuremarketinsights.com For web - https://www.futuremarketinsights.com/ **SOURCE:** Future Market Insights, Inc. View the original press release on ACCESS Newswire ### 相關股票 - [PBE.US](https://longbridge.com/zh-HK/quote/PBE.US.md) - [SY1.DE](https://longbridge.com/zh-HK/quote/SY1.DE.md) - [SBIO.US](https://longbridge.com/zh-HK/quote/SBIO.US.md) - [XBI.US](https://longbridge.com/zh-HK/quote/XBI.US.md) - [O6Z.SG](https://longbridge.com/zh-HK/quote/O6Z.SG.md) - [SHF.DE](https://longbridge.com/zh-HK/quote/SHF.DE.md) - [LABU.US](https://longbridge.com/zh-HK/quote/LABU.US.md) - [BAS.DE](https://longbridge.com/zh-HK/quote/BAS.DE.md) - [BASFY.US](https://longbridge.com/zh-HK/quote/BASFY.US.md) - [BIB.US](https://longbridge.com/zh-HK/quote/BIB.US.md) - [BBH.US](https://longbridge.com/zh-HK/quote/BBH.US.md) - [FBT.US](https://longbridge.com/zh-HK/quote/FBT.US.md) - [SAC.DE](https://longbridge.com/zh-HK/quote/SAC.DE.md) - [IBB.US](https://longbridge.com/zh-HK/quote/IBB.US.md) - [LZAGY.US](https://longbridge.com/zh-HK/quote/LZAGY.US.md) ## 相關資訊與研究 - [巴斯夫將進一步削減成本，重點關注核心業務](https://longbridge.com/zh-HK/news/287098958.md) - [美國啓動對越南化學品進口的調查](https://longbridge.com/zh-HK/news/287007343.md) - [鉅亨速報 - Factset 最新調查：Roivant Sciences LtdROIV-US 的目標價調升至 38 元，幅度約 8.57%](https://longbridge.com/zh-HK/news/287126179.md) - [復宏漢霖：注射用 HLX43 用於治療晚期非小細胞肺癌的國際多中心 2 期臨牀研究完成首例患者給藥](https://longbridge.com/zh-HK/news/287195179.md) - [儲局會議記錄顯示 大多數官員警告通脹率若持續高於 2% 需考慮加息](https://longbridge.com/zh-HK/news/287171073.md)